Breast Cancer Patients Could Extend Life Almost 16 Months With New Roche Drug

September 29, 2014 9:45 PM

3 0

Breast Cancer Patients Could Extend Life Almost 16 Months With New Roche Drug

A new breast cancer drug from Roche could significantly lengthen the lives of women battling invasive forms of breast cancer.

Women with a type of cancer called HER2 positive (which makes up a quarter of all breast cancer cases) were found to experience "unprecedented" benefits as a result of the drug Perjeta, Reuters reported. Women who took the drug in combination with the medicine Herceptin and chemotherapy lived an ave...

Read more

To category page

Loading...